# Fisher Wallace Laboratories, Inc. — Form D

Fisher Wallace Laboratories, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-13. The offering totals $5.0M. Industry: Biotechnology.

## Offering

- Filed: 2025-06-13
- Form: D
- Accession: 0001787792-25-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $3K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-548894

## Issuer

- Name: Fisher Wallace Laboratories, Inc.
- CIK: 0001787792
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 630 FLUSHING AVENUE, BOX 104, BROOKLYN, NY, 11206
- Phone: 917-930-4332

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Charles Avery Fisher | Director | BROOKLYN, NY |
| Kelly Joseph Roman | Director | BROOKLYN, NY |
| Kelly Joseph Roman | Executive Officer | BROOKLYN, NY |
| Charles Fisher | Director | San Francisco, CA |
| Charles Fisher | Executive Officer | San Francisco, CA |
| Simon Webster | Director | Jersey, Y7 |
| Kelly Roman | Director | Brooklyn, NY |
| Kelly Roman | Executive Officer | Brooklyn, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-07-26](https://search.stillhousedata.com/formd/0001787792-22-000001) | D | $750K | $250K |

## More

- [CIK 1787792 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1787792&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001787792-25-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.